文献速递免疫规划

家长对B型脑膜炎球菌疫苗的认知与接种意愿

Parental awareness of Meningococcal B vaccines and willingness to vaccinate their teens.
PubMed 文献 · Vaccine · 2018-12-23

2017-18年明尼苏达州立集市调查445名高中生家长,多数未听说过MenB疫苗(Bexsero® 80.0%,Trumenba® 82.0%)或MenACWY疫苗(Menactra®/Menveo® 68.8%),但89.6%至少 somewhat 愿意给青少年接种MenB疫苗,91.2%愿意接种MenACWY疫苗;MenB疫苗认知(OR: 3.8; 95% CI: 1.2-12.2)和脑膜炎球菌病担忧(OR: 3.1; 95% CI: 1.5-6.3)与MenB接种意愿显著相关。

要点

  • 多数家长未听说过MenB疫苗或MenACWY疫苗商品名。
  • 家长对MenB和MenACWY疫苗的接种意愿均较高。
  • MenB疫苗认知和疾病担忧与接种意愿显著相关。

核心结论

  • 青少年家长对MenB疫苗认知不足,但认知是接种意愿的重要预测因素。

研究设计与样本

  • 2017-18年明尼苏达州立集市期间对445名高中生家长进行iPad问卷调查,采用调整logistic回归分析。

主要发现

  • 80.0%(95% CI: 76.0-83.6)家长未听说过Bexsero®,82.0%(95% CI: 78.1-85.5)未听说过Trumenba®,68.8%(95% CI: 64.2-73.0)未听说过Menactra®或Menveo®。
  • 89.6%(95% CI: 86.5-92.3)家长至少 somewhat 愿意给青少年接种MenB疫苗,91.2%(95% CI: 88.2-93.7)愿意接种MenACWY疫苗。
  • MenB疫苗认知(OR: 3.8; 95% CI: 1.2-12.2)和脑膜炎球菌病担忧(OR: 3.1; 95% CI: 1.5-6.3)与MenB疫苗接种意愿显著相关。

临床怎么用

  • 公共卫生人员应加强家长对MenB疫苗的认知教育,以提升接种意愿。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the US, Meningococcal B (MenB) vaccines were first licensed in 2014. In 2015, the Advisory Committee on Immunization Practices recommended that parents of teens talk to their provider about receiving MenB vaccine, rather than issuing a routine recommendation. We assessed parental awareness of MenB vaccines and willingness to vaccinate their teens with MenB vaccines compared to MenACWY vaccines, which have been routinely recommended for many years. METHODS: We surveyed parents of teens attending high school in 2017-18 during the Minnesota State Fair. Parents reported via iPad their knowledge of and concern about meningococcal disease and their awareness of and willingness to vaccinate with MenB and MenACWY vaccines. We assessed the relationship between meningococcal disease knowledge and concern, MenB and MenACWY vaccine awareness, and willingness to vaccinate with MenB and MenACWY using adjusted logistic regression. RESULTS: Among 445 parents, the majority had not heard of the newly introduced MenB vaccines Bexsero® (80.0%; 95% CI: 76.0-83.6) or Trumenba® (82.0%; 95% CI: 78.1-85.5) or the MenACWY vaccines Menactra® or Menveo® (68.8%; 95% CI: 64.2-73.0). The majority were at least somewhat willing to vaccinate their teen with MenB vaccine (89.6%; 95% CI: 86.5, 92.3) and MenACWY vaccine (91.2%; 95% CI: 88.2, 93.7). Awareness of MenB vaccines (OR: 3.8; 95% CI: 1.2-12.2) and concern about meningococcal disease (OR: 3.1; 95% CI: 1.5-6.3) were significantly associated with willingness to vaccinate with MenB vaccine. CONCLUSIONS: Awareness of MenB vaccine is lacking among parents of teens but is an important predictor of willingness to vaccinate with the newly licensed MenB vaccines.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Basta NE, Becker AB, Li Q, et al. Parental awareness of Meningococcal B vaccines and willingness to vaccinate their teens. Vaccine. 2018. PMID: 30587431. doi:10.1016/j.vaccine.2018.11.078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。